Precision Targeted Therapy with BLU-667 for RET-Driven Cancers.
Cancer Discov. 2018 Jul;8(7):836-849. doi: 10.1158/2159-8290.CD-18-0338. Epub 2018 Apr 15.
Cancer Discov. 2018.
PMID: 29657135